GNMX
Aevi Genomic Medicine, Inc.
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
27 hedge funds and large institutions have $17.2M invested in Aevi Genomic Medicine, Inc. in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.
Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
5
Closed
4
Calls
$789K
Puts
–
Net Calls
+$789K
Net Calls Change
+$208K
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Barclays
London,
United Kingdom
| $5K | 700 | +700 | New |
|
27
BNP Paribas Financial Markets
Paris,
France
| $2.39K | 308 | – | – |
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | -21,075 | Closed |
|
|
KCPG
29
Kavar Capital Partners Group
Leawood,
Kansas
| – | – | -2,000 | Closed |
|
|
TDC
30
Thompson Davis & Co
Richmond,
Virginia
| – | – | -750 | Closed |
|
|
SSG
31
Summit Securities Group
New York
| – | – | -25 | Closed |
|